Pregled bibliografske jedinice broj: 10383
Commentary on article by Rudavsky and Freeman - Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine 131-I and recombinant human thyroid stimulating hormone
Commentary on article by Rudavsky and Freeman - Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine 131-I and recombinant human thyroid stimulating hormone // The Journal of clinical endocrinology and metabolism, 82 (1997), 12; 4277-4278 (međunarodna recenzija, pismo, znanstveni)
CROSBI ID: 10383 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Commentary on article by Rudavsky and Freeman - Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine 131-I and recombinant human thyroid stimulating hormone
Autori
Lukinac, Ljerka ; Franceschi, Dinko ; Kusić, Zvonko
Izvornik
The Journal of clinical endocrinology and metabolism (0021-972X) 82
(1997), 12;
4277-4278
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pismo, znanstveni
Ključne riječi
radioiodine scan; thyroglobulin; thyroid carcinoma; metastases
Sažetak
We read with great interest the case report by Rudavsky and Freeman (1) presenting the use of recombinant human TSH (rh TSH) to stimulate uptake of 131I in the treatment of metastatic differentiated thyroid cancer (DTC). With this exciting approach one could avoid the necessity to withdraw thyroid supression therapy and associated hypothyroid morbidity. However, we found a few missing points and inconsistencies in the clinical course of that report...
Izvorni jezik
Engleski
Znanstvena područja
Javno zdravstvo i zdravstvena zaštita
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
